Background Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia
and now poses a threat to the control and elimination of malaria. Mapping the geographic …

Background Oral ivermectin is a safe broad spectrum anthelminthic used for treating several
neglected tropical diseases (NTDs). Currently, ivermectin use is contraindicated in children …

Background The emergence and spread of resistance in Plasmodium falciparum malaria to
artemisinin combination therapies in the Greater Mekong subregion poses a major threat to …

Background Artemisinin and partner-drug resistance in Plasmodium falciparum are major
threats to malaria control and elimination. Triple artemisinin-based combination therapies (…

Background KAE609 (cipargamin; formerly NITD609, Novartis Institute for Tropical Diseases)
is a new synthetic antimalarial spiroindolone analogue with potent, dose-dependent …

Background A multidrug-resistant co-lineage of Plasmodium falciparum malaria, named
KEL1/PLA1, spread across Cambodia in 2008–13, causing high rates of treatment failure with …

Background Artefenomel (OZ439) is a novel synthetic trioxolane with improved pharmacokinetic
properties compared with other antimalarial drugs with the artemisinin pharmacophore. …

The emergence and spread of artemisinin-resistant Plasmodium falciparum, first in the
Greater Mekong Subregion (GMS), and now in East Africa, is a major threat to global malaria …

Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …

Background KAF156 belongs to a new class of antimalarial agents (imidazolopiperazines),
with activity against asexual and sexual blood stages and the preerythrocytic liver stages of …